Synthesis and antibacterial activity of novel modified 5-O-desosamine ketolides. 2012

Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Beijing Key Laboratory of Active Substances Discovery and Drugability Evaluation, Department of Medicinal Chemistry, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100050, PR China.

A series of novel modified 5-O-desosamine-ketolides were synthesized. The 5-O-desosamine fragment was removed from ketolide by an efficient and mild manipulation. 4-O-substituted desosamine was introduced into the ketolide aglycon and various coupling methods were essayed for the glycosylation. Three novel ketolides were tested for in vitro antibacterial activity against a panel of susceptible and resistant pathogens. Compound 26 showed potent activity against all the methicillin-sensitivity and resistant pathogens.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013212 Staphylococcus epidermidis A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader.
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017108 Streptococcus Phages Viruses whose host is Streptococcus. Streptococcal Phages,Streptococcus Bacteriophages,Bacteriophage, Streptococcus,Bacteriophages, Streptococcus,Phage, Streptococcal,Phage, Streptococcus,Phages, Streptococcal,Phages, Streptococcus,Streptococcal Phage,Streptococcus Bacteriophage,Streptococcus Phage
D048628 Ketolides Compounds based on ERYTHROMYCIN with the 3-cladinose replaced by a ketone. They bind the 23S part of 70S bacterial RIBOSOMES. 3-Keto-Erythromycins,Erythromycins, 3-Keto,3 Keto Erythromycins,3-Keto Erythromycins,Erythromycins, 3 Keto

Related Publications

Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
July 2012, Bioorganic & medicinal chemistry letters,
Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
April 2010, Bioorganic & medicinal chemistry letters,
Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
March 2006, Journal of medicinal chemistry,
Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
August 2006, Bioorganic & medicinal chemistry,
Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
August 2017, Bioorganic & medicinal chemistry letters,
Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
May 2012, Bioorganic & medicinal chemistry letters,
Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
May 2004, Bioorganic & medicinal chemistry letters,
Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
September 2012, Bioorganic & medicinal chemistry letters,
Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
December 2006, Bioorganic & medicinal chemistry letters,
Xiaozhuo Chen, and Peng Xu, and Yanpeng Xu, and Lu Liu, and Yi Liu, and Di Zhu, and Pingsheng Lei
August 2018, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!